Blomberg, O. S., Kos, K., Spagnuolo, L., Isaeva, O. I., Garner, H., Wellenstein, M. D., . . . de Visser, K. E. (2023). Neoadjuvant immune checkpoint blockade triggers persistent and systemic Treg activation which blunts therapeutic efficacy against metastatic spread of breast tumors. Oncoimmunology, 12(1), 2201147. https://doi.org/10.1080/2162402X.2023.2201147
Citace podle Chicago (17th ed.)Blomberg, Olga S., et al. "Neoadjuvant Immune Checkpoint Blockade Triggers Persistent and Systemic Treg Activation Which Blunts Therapeutic Efficacy Against Metastatic Spread of Breast Tumors." Oncoimmunology 12, no. 1 (2023): 2201147. https://doi.org/10.1080/2162402X.2023.2201147.
Citace podle MLA (9th ed.)Blomberg, Olga S., et al. "Neoadjuvant Immune Checkpoint Blockade Triggers Persistent and Systemic Treg Activation Which Blunts Therapeutic Efficacy Against Metastatic Spread of Breast Tumors." Oncoimmunology, vol. 12, no. 1, 2023, p. 2201147, https://doi.org/10.1080/2162402X.2023.2201147.